In 1957 was created SNBL USA, which is appeared as Corporate Investor.
The top activity for fund was in 2015. The increased amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are RA Capital Management. In the next rounds fund is usually obtained by Teva Pharmaceutical Industries, Redmile Group, RA Capital Management.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Wave Life Sciences. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device.
| Fund Name | Location |
| APAC Realty | Central, Central Region, Singapore |
| Atrinum. | Ventures | Switzerland, Zug, Zug |
| Beta Catalyst | Chiyoda, Japan |
| BioMed Ventures | California, San Diego, United States |
| Canna Angels | - |
| Frontier Communications | Connecticut, Stamford, United States |
| GaneshaLab | Chile, Region Metropolitana, Santiago |
| Hengqinhexiang Venture | China, Guangdong, Zhuhai |
| Key Venture Partners | Boston, Massachusetts, United States |
| Luzerner Kantonalbank | Lucerne, Luzern, Switzerland |
| Rockefeller Financial Services | California, Los Angeles, United States |
| Shanghai Media Group | China, Shanghai |
| Start it Labs, LLC | Bellevue, United States, Washington |
| SVB Leerink | Boston, Massachusetts, United States |
| Techtronic Industries | - |
| Tianchuang Zhixing (Beijing) Touzi Guanli Zixun Youxian Gongsi | Beijing, China, Haidian |
| Waaree | India, Maharashtra, Mumbai |
| YC Tec | - |
| Zhangshushi Fenghua Touzi guanli Zhongxin | China, Guangdong, Jiangxi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Wave Life Sciences | $18M | 02 Feb 2015 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Wave Life Sciences | $18M | 02 Feb 2015 | Boston, Massachusetts, United States |
